Chronic lymphocytic leukemia presenting as an intracranial epidural mass in a patient with myeloproliferative neoplasm associated with JAK2 V617F mutation.

about

Chronic lymphocytic leukemia presenting as an intracranial epidural mass in a patient with myeloproliferative neoplasm associated with JAK2 V617F mutation.

Item

http://www.wikidata.org/entity/Q48326539

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Chronic lymphocytic leukemia p ...... ated with JAK2 V617F mutation.

@en

Chronic lymphocytic leukemia p ...... ated with JAK2 V617F mutation.

@nl

type

Item

label

Chronic lymphocytic leukemia p ...... ated with JAK2 V617F mutation.

@en

Chronic lymphocytic leukemia p ...... ated with JAK2 V617F mutation.

@nl

prefLabel

Chronic lymphocytic leukemia p ...... ated with JAK2 V617F mutation.

@en

Chronic lymphocytic leukemia p ...... ated with JAK2 V617F mutation.

@nl

P1476

Chronic lymphocytic leukemia p ...... ated with JAK2 V617F mutation.

@en

P2093

Ali Bazargan

http://www.w3.org/2001/XMLSchema#string

Frank Firkin

http://www.w3.org/2001/XMLSchema#string

Kah-Lok Chan

http://www.w3.org/2001/XMLSchema#string

Penny McKelvie

http://www.w3.org/2001/XMLSchema#string

P2860

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

JAK mutations in high-risk childhood acute lymphoblastic leukemia

Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.

Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review.

Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.

Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell?

Cerebral involvement as the initial manifestation of chronic lymphocytic leukaemia.

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy.

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.

P304

1110-1112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2012.726723

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Constantine S. Tam

P577

2012-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23088192

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte